Long-Term Follow-Up Study of Inferonasal Minimally Invasive Micro Sclerostomy MIMS4 Surgery for Open Angle Glaucoma

What this Trial Is About

Researchers are conducting a long-term follow-up extension study to collect data from people who have previously had the Minimally Invasive Micro Sclerostomy MIMS4 inferonasal surgery. This observational study aims to evaluate changes in intraocular pressure and the use of eye pressure-lowering medications over 24 and 30 months after the surgery. The study also monitors the success rate of the surgery and safety outcomes related to postoperative complications and interventions. Participants in this study are those who underwent the MIMS4 inferonasal procedure using the proprietary MIMS4 device, which creates a small opening in the inferonasal part of the eye. This study involves one group of participants who have already had this surgery, and it focuses on collecting follow-up data without introducing any new treatments or interventions. During the study, participants will be observed over periods of 24 and 30 months post-surgery. Researchers will measure intraocular pressure changes, track the number of topical medications used to lower eye pressure, and assess the long-term safety and success of the surgery. No additional procedures are performed, and the study mainly involves data collection from previous surgical patients. The total participation duration aligns with the 30 months of follow-up after their prior surgery.

Inferonasal MIMS® Procedure: Long-Term Follow-Up Extension Study